Skip to main content

Clinical Trial Site Visit- ABC of Clinical Trial Management/Monitoring

"Clinical Trial Monitoring refers to the methods used by sponsors of investigational studies or CROs delegated responsibilities for the conduct of IND studies, to oversee the conduct of, and reporting of data from, clinical investigations, including appropriate CI supervision of study site staff and third-party contractors. Monitoring activities include communication with the CI and study site staff; review of the study site’s processes, procedures, and records; and verification of the accuracy of data submitted to the sponsor. " FDA Guidance 2013

Monitoring of clinical trials is necessary to assure that
- rights and safety of patients (i.e. human subjects) are protected
- reported trial data are accurate, complete, and verifiable from the source of documents
- conduct of trails in compliance with the protocol, good clinical practice (GCP), and applicable regulatory requirements


Clinical Trial Visit by Sponsors
- Pre-study Qualification Visit
- Initiation Visit
- Monitoring Visit
-Closeout Visit


Pre-study Qualification Visit
- The purpose of the qualification visit is to assess the site's ability to conduct the clinical trial prior to the initiation of the investigation.
- During this visit the clinical research associate or the sponsor representative
- Visit the site
- Meet with study staff
- Inspect the facilities
- Assess Site Documentation Source & Practice
- Document investigator experience, workload, participation
- Document Patient source, staff allocation, adequacy site, and lab facilities
- 2-3 hours for the visit


Initiation Visit

- The purpose of the initiation visit is to assure that PI and staff understand their obligations of the study conduct, and to identify potential problems and concerns.
- During this visit, the sponsors provide describes the expectation such as 
- Roles and responsibility of PI, 
- Protocol procedures, 
- CRF completion instruction review, 
- Requirement for records management and retention
- Drug handling requirements
- Enrollment and Consent procedures
- Adverse event reporting procedure 
- Patient recruitment process

Timing of the visit:
-The visit occurs prior to the patient enrollment, after all the documentation are in place, supplies are received, and IRB approval of the study protocol





Comments

Popular posts from this blog

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

                                      MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

MCQs and Answers on cultivation (culture/incubation), Isolation and Identification of microorganisms: Medical Microbiology

40 plus questions - Multiple Choice Questions on Classification, Culture, and Identification of the microorganisms 1. Which of the following microorganism has the cocci cell shapes and sizes arranged usually in tetrad structures? a)  Streptococcus pneumoniae b)  Staphylococcus aureus c)  Chlamydia trachomatis d)  Neisseria meningitidis 2. What are the different growth morphology and cell structures used for the classification of fungi? Select all the correct answers: a) Yeast b) Mold c) Mycelia d) Protozoa 3. Which of the following media is formulated with additional nutrients to support the growth of fastidious or nutritionally demanding bacteria that may not grow well on basic media? a) Differential media b) Enriched media c) Nutrient agar (media) d) Selective media 4. Which of the following metabolic characteristic is a distinguishing characteristic and identification of colonies of  E. coli ? a) Hydrogen sulfide formation b) Indole Formation c) Lactose fe...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

                                        MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia.  Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance  c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells.  c) Patients with  uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above   3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose  c) Insulin ...